{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T02:46:46Z","timestamp":1789958806633,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1038\/leu.2015.96","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T08:43:00Z","timestamp":1430469780000},"page":"2263-2266","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors"],"prefix":"10.1038","volume":"29","author":[{"given":"W","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J L","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L J","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"BFleu201596_CR1","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1053\/j.seminoncol.2011.11.002","volume":"39","author":"T Ernst","year":"2012","unstructured":"Ernst T, Hochhaus A . Chronic myeloid leukemia: clinical impact of BCR-ABL1 mutations and other lesions associated with disease progression. Semin Oncol 2012; 39: 58\u201366.","journal-title":"Semin Oncol"},{"key":"BFleu201596_CR2","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1182\/blood-2011-08-373902","volume":"118","author":"A Fabarius","year":"2011","unstructured":"Fabarius A, Leitner A, Hochhaus A, Muller MC, Hanfstein B, Haferlach C et al. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood 2011; 118: 6760\u20136768.","journal-title":"Blood"},{"key":"BFleu201596_CR3","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1182\/blood-2011-10-384651","volume":"120","author":"S Luatti","year":"2012","unstructured":"Luatti S, Castagnetti F, Marzocchi G, Baldazzi C, Gugliotta G, Iacobucci I et al. Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis. Blood 2012; 120: 761\u2013767.","journal-title":"Blood"},{"key":"BFleu201596_CR4","doi-asserted-by":"publisher","first-page":"3794","DOI":"10.1182\/blood-2002-09-2790","volume":"101","author":"JE Cortes","year":"2003","unstructured":"Cortes JE, Talpaz M, Giles F, O'Brien S, Rios MB, Shan J et al. Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy. Blood 2003; 101: 3794\u20133800.","journal-title":"Blood"},{"key":"BFleu201596_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000046636","volume":"107","author":"B Johansson","year":"2002","unstructured":"Johansson B, Fioretos T, Mitelman F . Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 2002; 107: 76\u201394.","journal-title":"Acta Haematol"},{"key":"BFleu201596_CR6","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00277-012-1421-6","volume":"91","author":"Q Mu","year":"2012","unstructured":"Mu Q, Ma Q, Wang Y, Chen Z, Tong X, Chen FF et al. Cytogenetic profile of 1,863 Ph\/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population. Ann Hematol 2012; 91: 1065\u20131072.","journal-title":"Ann Hematol"},{"key":"BFleu201596_CR7","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/leu.2010.67","volume":"24","author":"BA Burke","year":"2010","unstructured":"Burke BA, Carroll M . BCR-ABL: a multi-faceted promoter of DNA mutation in chronic myelogeneous leukemia. Leukemia 2010; 24: 1105\u20131112.","journal-title":"Leukemia"},{"key":"BFleu201596_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1182\/blood-2012-03-380147","volume":"120","author":"R Hehlmann","year":"2012","unstructured":"Hehlmann R . How I treat CML blast crisis. Blood 2012; 120: 737\u2013747.","journal-title":"Blood"},{"key":"BFleu201596_CR9","first-page":"179","volume-title":"Cancer Cytogenetics","author":"T Fioretos","year":"2009","unstructured":"Fioretos T, Johansson B . Chronic myeloid anchor leukemia. In: Heim S, Mitelman F (eds). Cancer Cytogenetics. Wiley-Blackwell: Hoboken, NJ, USA, 2009; pp 179\u2013207."},{"key":"BFleu201596_CR10","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia. 2013 Blood 2013; 122: 872\u2013884.","journal-title":"Blood"},{"key":"BFleu201596_CR11","first-page":"32","volume-title":"WHO Classifiction of Tumours of Haematopoietic and Lymphoid Tissues","author":"JW Vardiman","year":"2008","unstructured":"Vardiman JW, Melo JV, Baccarani M, Thiele J . Chronic myelogenous leukaemia, BCR-ABL1 positive. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds). WHO Classifiction of Tumours of Haematopoietic and Lymphoid Tissues. IARC: Lyon, 2008; pp 32\u201337."},{"key":"BFleu201596_CR12","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/cncr.25015","volume":"116","author":"D Verma","year":"2010","unstructured":"Verma D, Kantarjian H, Shan J, O'Brien S, Estrov Z, Garcia-Manero G et al. Survival outcomes for clonal evolution in chronic myeloid leukemia patients on second generation tyrosine kinase inhibitor therapy. Cancer 2010; 116: 2673\u20132681.","journal-title":"Cancer"},{"key":"BFleu201596_CR13","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3324\/haematol.2009.019109","volume":"95","author":"E Lippert","year":"2010","unstructured":"Lippert E, Etienne G, Mozziconacci MJ, Laibe S, Gervais C, Girault S et al. Loss of the Y chromosome in Philadelphia-positive cells predicts a poor response of chronic myeloid leukemia patients to imatinib mesylate therapy. Haematologica 2010; 95: 1604\u20131607.","journal-title":"Haematologica"},{"key":"BFleu201596_CR14","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","volume":"120","author":"PL Greenberg","year":"2012","unstructured":"Greenberg PL, Tuechler H, Schanz J, Sanz G, Garcia-Manero G, Sole F et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120: 2454\u20132465.","journal-title":"Blood"},{"key":"BFleu201596_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood.V100.1.29","volume":"100","author":"SR Wolman","year":"2002","unstructured":"Wolman SR, Gundacker H, Appelbaum FR, Slovak ML . Southwest Oncology G. Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study. Blood 2002; 100: 29\u201335.","journal-title":"Blood"},{"key":"BFleu201596_CR16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/leu.2014.114","volume":"28","author":"H Becker","year":"2014","unstructured":"Becker H, Maharry K, Mrozek K, Volinia S, Eisfeld AK, Radmacher MD et al. Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8. Leukemia 2014; 28: 1754\u20131758.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201596","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201596.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T19:05:44Z","timestamp":1717873544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["BFleu201596"],"URL":"https:\/\/doi.org\/10.1038\/leu.2015.96","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]},"assertion":[{"value":"14 April 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}